General Page Media
University of Minnesota investigators will require Institutional Biosafety Committee (IBC) approval to work with reagents produced by the VVCC. It is important to submit an IBC protocol, or an IBC protocol amendment, as soon as possible once committing to seeking VVCC support for your efforts. To facilitate this process, we have prepared documents that will help you secure IBC permission for work with recombinant DNA and/or viral vectors:
Projects involving AAV vectors
Projects involving lentiviral vectors (2nd generation)
Projects involving lentiviral vectors (3rd generation)
The IBC protocol for the VVCC is 2108-39321H (latest approval date: 09/15/2023)